AK
Anila Kumari Bhandary
About Anila Kumari Bhandary
Data last updated:
Anila Kumari Bhandary is a Director at Saspinjira Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Saspinjira Pharmaceuticals Private Limited U46497KA2024PTC188539 | Director | 15 May 2024 | 2024 | Active |
Board colleagues of Anila Kumari Bhandary
| Name | DIN | Company | Designation |
|---|---|---|---|
| Channabasava Swamy Hiremath | 09071471 | Saspinjira Pharmaceuticals Private Limited | Director |
| Deviprasad Shetty | 10628726 | Saspinjira Pharmaceuticals Private Limited | Director |
| Rajeev Bisati | 07307852 | Saspinjira Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anila Kumari Bhandary
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anila Kumari Bhandary
Anila Kumari Bhandary currently holds 1 directorship: Saspinjira Pharmaceuticals Private Limited (Director, since 15 May 2024).
Anila Kumari Bhandary was first appointed on 15 May 2024 as Director at Saspinjira Pharmaceuticals Private Limited.
The current boards of Anila Kumari Bhandary's companies include Channabasava Swamy Hiremath (Saspinjira Pharmaceuticals Private Limited), Deviprasad Shetty (Saspinjira Pharmaceuticals Private Limited), Rajeev Bisati (Saspinjira Pharmaceuticals Private Limited).